Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
108
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan

Kashif Asghar1 Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan, [email protected]Correspondence[email protected]
,
Asif Loya2 Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan
,
Iftikhar Ali Rana2 Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan
,
Muhammad Tahseen2 Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan
,
Muhammad Ishaq2 Department of Pathology, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan
,
Asim Farooq3 Department of Biomedical Engineering & Sciences, School of Mechanical & Manufacturing Engineering, National University of Sciences & Technology (NUST), Islamabad, Pakistan
,
Muhammad Abu Bakar4 Department of Cancer Registry and Clinical Data Management, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan
&
Iqra Masood5 Department of Clinical Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan
 show all
Pages 475-481 | Published online: 03 Jan 2019

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gamze Guney Eskiler & Cemil Bilir. (2021) The efficacy of indoximod upon stimulation with pro-inflammatory cytokines in triple-negative breast cancer cells. Immunopharmacology and Immunotoxicology 43:5, pages 554-561.
Read now

Articles from other publishers (20)

Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Túlio Teruo Yoshinaga, Maria Lucia Zaidan Dagli, Cristina de Oliveira Massoco & Jose Roberto Kfoury Junior. (2023) Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. Molecular Biology Reports 50:7, pages 6133-6145.
Crossref
Sarah Y. Kado, Keith Bein, Alejandro R. Castaneda, Arshia A. Pouraryan, Nicole Garrity, Yasuhiro Ishihara, Andrea Rossi, Thomas Haarmann-Stemmann, Colleen A. Sweeney & Christoph F. A. Vogel. (2023) Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer. Cells 12:10, pages 1433.
Crossref
Hossein Javid, Fatemeh Attarian, Toktam Saadatmand, Nastaran Rezagholinejad, Ali Mehri, Hamed Amiri & Mehdi Karimi‐Shahri. (2023) The therapeutic potential of immunotherapy in the treatment of breast cancer: Rational strategies and recent progress. Journal of Cellular Biochemistry 124:4, pages 477-494.
Crossref
Avinash Khadela, Shruti Soni, Kaivalya Megha, Aayushi C. Shah, Aanshi J. Pandya, Nirjari Kothari, Ishika Shah & C. B. Avinash. (2022) Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects. Medical Oncology 40:1.
Crossref
Alicia González-González, Aurora Laborda-Illanes, Soukaina Boutriq, Lidia Sánchez-Alcoholado, Daniel Castellano-Castillo, Isaac Plaza-Andrades, Jesús Peralta-Linero & María Isabel Queipo-Ortuño. 2022. Melatonin - Recent Updates. Melatonin - Recent Updates.
Haiyan Zhang, Jing Li & Qi Zhou. (2022) Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis. Frontiers in Oncology 12.
Crossref
Kashif Asghar, Muhammad Abu Bakar, Sara Ashfaq, Asim Munir Alvi, Waqas Shafiq, Umal Azmat, Ahmed Imran Siddiqi, Asim Farooq, Rabail Raza & Kashif Siddique. (2022) COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management. Frontiers in Oncology 12.
Crossref
Xinchun Zhao, Yujia Jiang, Ming Xu, Jin Hu, Nan Feng, Huifang Deng, Chong Lu & Tao Huang. (2022) Indoleamine 2,3-dioxygenase 1 regulates breast cancer tamoxifen resistance through interleukin-6/signal transducer and activator of transcription. Toxicology and Applied Pharmacology 440, pages 115921.
Crossref
Saptadip Samanta. (2022) Melatonin: A Potential Antineoplastic Agent in Breast Cancer. Journal of Environmental Pathology, Toxicology and Oncology 41:4, pages 55-84.
Crossref
Getinet M. Adinew, Equar Taka, Bereket Mochona, Ramesh B. Badisa, Elizabeth A. Mazzio, Rashid Elhag & Karam F. A. Soliman. (2021) Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment. Nutrients 14:1, pages 79.
Crossref
Yifeng Cao, Chuyang Chen, Yi Tao, Weifeng Lin & Ping Wang. (2021) Immunotherapy for Triple-Negative Breast Cancer. Pharmaceutics 13:12, pages 2003.
Crossref
Fayyaz Ahmed, Muhammad Adnan, Ayesha Malik, Somayya Tariq, Farukh Kamal & Bushra Ijaz. (2021) Perception of breast cancer risk factors: Dysregulation of TGF-β/miRNA axis in Pakistani females. PLOS ONE 16:7, pages e0255243.
Crossref
Kashif Asghar, Asim Farooq, Bilal Zulfiqar & Asif Loya. (2021) Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase. World Journal of Clinical Oncology 12:6, pages 429-436.
Crossref
Kashif Asghar, Muhammad Abu Bakar, Muhammad Junaid Akram, Asim Farooq, Kashif Siddique, Iftikhar Ali Rana, Jamshed Ali, Muhammad Usman Rashid, Ashraf Ali Khan & Asif Loya. (2021) Clinical Characteristics of COVID-19-Infected Cancer Patients in Pakistan: Differences Between Survivors and Non-Survivors. Frontiers in Oncology 11.
Crossref
Yasser Tabana, Isobel S. Okoye, Arno Siraki, Shokrollah Elahi & Khaled H. Barakat. (2021) Tackling Immune Targets for Breast Cancer: Beyond PD-1/PD-L1 Axis. Frontiers in Oncology 11.
Crossref
Kashif Asghar, Asif Loya, Iftikhar Ali Rana, Muhammad Abu Bakar, Asim Farooq, Muhammad Tahseen, Muhammad Ishaq, Iqra Masood & Muhammad Usman Rashid. (2020) Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients. World Journal of Clinical Oncology 11:12, pages 1018-1028.
Crossref
George Anderson. (2019) Breast cancer: Occluded role of mitochondria N-acetylserotonin/melatonin ratio in co-ordinating pathophysiology. Biochemical Pharmacology 168, pages 259-268.
Crossref
Vanessa Barriga, Nyanbol Kuol, Kulmira Nurgali & Vasso Apostolopoulos. (2019) The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer. Cancers 11:8, pages 1205.
Crossref
Sebastian Chrétien, Ioannis Zerdes, Jonas Bergh, Alexios Matikas & Theodoros Foukakis. (2019) Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy. Cancers 11:5, pages 628.
Crossref
Xiaojun Yang, Shi Cai, Xueting Liu, Pan Chen, Jinpei Zhou & Huibin Zhang. (2019) Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors. Bioorganic & Medicinal Chemistry 27:8, pages 1605-1618.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.